Cargando…
Genetic Disruption of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Triggers Differential Cardiac Fibrosis and Disorders in Male and Female Mutant Mice: Role of TGF-β1/SMAD Signaling Pathway
The global targeted disruption of the natriuretic peptide receptor-A (NPRA) gene (Npr1) in mice provokes hypertension and cardiovascular dysfunction. The objective of this study was to determine the mechanisms regulating the development of cardiac fibrosis and dysfunction in Npr1 mutant mice. Npr1 k...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569686/ https://www.ncbi.nlm.nih.gov/pubmed/36232788 http://dx.doi.org/10.3390/ijms231911487 |
_version_ | 1784809916189376512 |
---|---|
author | Subramanian, Umadevi Ramasamy, Chandramohan Ramachandran, Samivel Oakes, Joshua M. Gardner, Jason D. Pandey, Kailash N. |
author_facet | Subramanian, Umadevi Ramasamy, Chandramohan Ramachandran, Samivel Oakes, Joshua M. Gardner, Jason D. Pandey, Kailash N. |
author_sort | Subramanian, Umadevi |
collection | PubMed |
description | The global targeted disruption of the natriuretic peptide receptor-A (NPRA) gene (Npr1) in mice provokes hypertension and cardiovascular dysfunction. The objective of this study was to determine the mechanisms regulating the development of cardiac fibrosis and dysfunction in Npr1 mutant mice. Npr1 knockout (Npr1(−/−), 0-copy), heterozygous (Npr1(+/−), 1-copy), and wild-type (Npr1(+/+), 2-copy) mice were treated with the transforming growth factor (TGF)-β1 receptor (TGF-β1R) antagonist GW788388 (2 µg/g body weight/day; ip) for 28 days. Hearts were isolated and used for real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR), Western blot, and immunohistochemical analyses. The Npr1(−/−) (0-copy) mice showed a 6-fold induction of cardiac fibrosis and dysfunction with markedly induced expressions of collagen-1α (3.8-fold), monocyte chemoattractant protein (3.7-fold), connective tissue growth factor (CTGF, 5.3-fold), α-smooth muscle actin (α-SMA, 6.1-fold), TGF-βRI (4.3-fold), TGF-βRII (4.7-fold), and phosphorylated small mothers against decapentaplegic (pSMAD) proteins, including pSMAD-2 (3.2-fold) and pSMAD-3 (3.7-fold), compared with wild-type mice. The expressions of phosphorylated extracellular-regulated kinase ERK1/2 (pERK1/2), matrix metalloproteinases-2, -9, (MMP-2, -9), and proliferating cell nuclear antigen (PCNA) were also significantly upregulated in Npr1 0-copy mice. The treatment of mutant mice with GW788388 significantly blocked the expression of fibrotic markers, SMAD proteins, MMPs, and PCNA compared with the vehicle-treated control mice. The treatment with GW788388 significantly prevented cardiac dysfunctions in a sex-dependent manner in Npr1 0-copy and 1-copy mutant mice. The results suggest that the development of cardiac fibrosis and dysfunction in mutant mice is predominantly regulated through the TGF-β1-mediated SMAD-dependent pathway. |
format | Online Article Text |
id | pubmed-9569686 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95696862022-10-17 Genetic Disruption of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Triggers Differential Cardiac Fibrosis and Disorders in Male and Female Mutant Mice: Role of TGF-β1/SMAD Signaling Pathway Subramanian, Umadevi Ramasamy, Chandramohan Ramachandran, Samivel Oakes, Joshua M. Gardner, Jason D. Pandey, Kailash N. Int J Mol Sci Article The global targeted disruption of the natriuretic peptide receptor-A (NPRA) gene (Npr1) in mice provokes hypertension and cardiovascular dysfunction. The objective of this study was to determine the mechanisms regulating the development of cardiac fibrosis and dysfunction in Npr1 mutant mice. Npr1 knockout (Npr1(−/−), 0-copy), heterozygous (Npr1(+/−), 1-copy), and wild-type (Npr1(+/+), 2-copy) mice were treated with the transforming growth factor (TGF)-β1 receptor (TGF-β1R) antagonist GW788388 (2 µg/g body weight/day; ip) for 28 days. Hearts were isolated and used for real-time quantitative reverse transcription polymerase chain reaction (qRT-PCR), Western blot, and immunohistochemical analyses. The Npr1(−/−) (0-copy) mice showed a 6-fold induction of cardiac fibrosis and dysfunction with markedly induced expressions of collagen-1α (3.8-fold), monocyte chemoattractant protein (3.7-fold), connective tissue growth factor (CTGF, 5.3-fold), α-smooth muscle actin (α-SMA, 6.1-fold), TGF-βRI (4.3-fold), TGF-βRII (4.7-fold), and phosphorylated small mothers against decapentaplegic (pSMAD) proteins, including pSMAD-2 (3.2-fold) and pSMAD-3 (3.7-fold), compared with wild-type mice. The expressions of phosphorylated extracellular-regulated kinase ERK1/2 (pERK1/2), matrix metalloproteinases-2, -9, (MMP-2, -9), and proliferating cell nuclear antigen (PCNA) were also significantly upregulated in Npr1 0-copy mice. The treatment of mutant mice with GW788388 significantly blocked the expression of fibrotic markers, SMAD proteins, MMPs, and PCNA compared with the vehicle-treated control mice. The treatment with GW788388 significantly prevented cardiac dysfunctions in a sex-dependent manner in Npr1 0-copy and 1-copy mutant mice. The results suggest that the development of cardiac fibrosis and dysfunction in mutant mice is predominantly regulated through the TGF-β1-mediated SMAD-dependent pathway. MDPI 2022-09-29 /pmc/articles/PMC9569686/ /pubmed/36232788 http://dx.doi.org/10.3390/ijms231911487 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Subramanian, Umadevi Ramasamy, Chandramohan Ramachandran, Samivel Oakes, Joshua M. Gardner, Jason D. Pandey, Kailash N. Genetic Disruption of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Triggers Differential Cardiac Fibrosis and Disorders in Male and Female Mutant Mice: Role of TGF-β1/SMAD Signaling Pathway |
title | Genetic Disruption of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Triggers Differential Cardiac Fibrosis and Disorders in Male and Female Mutant Mice: Role of TGF-β1/SMAD Signaling Pathway |
title_full | Genetic Disruption of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Triggers Differential Cardiac Fibrosis and Disorders in Male and Female Mutant Mice: Role of TGF-β1/SMAD Signaling Pathway |
title_fullStr | Genetic Disruption of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Triggers Differential Cardiac Fibrosis and Disorders in Male and Female Mutant Mice: Role of TGF-β1/SMAD Signaling Pathway |
title_full_unstemmed | Genetic Disruption of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Triggers Differential Cardiac Fibrosis and Disorders in Male and Female Mutant Mice: Role of TGF-β1/SMAD Signaling Pathway |
title_short | Genetic Disruption of Guanylyl Cyclase/Natriuretic Peptide Receptor-A Triggers Differential Cardiac Fibrosis and Disorders in Male and Female Mutant Mice: Role of TGF-β1/SMAD Signaling Pathway |
title_sort | genetic disruption of guanylyl cyclase/natriuretic peptide receptor-a triggers differential cardiac fibrosis and disorders in male and female mutant mice: role of tgf-β1/smad signaling pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9569686/ https://www.ncbi.nlm.nih.gov/pubmed/36232788 http://dx.doi.org/10.3390/ijms231911487 |
work_keys_str_mv | AT subramanianumadevi geneticdisruptionofguanylylcyclasenatriureticpeptidereceptoratriggersdifferentialcardiacfibrosisanddisordersinmaleandfemalemutantmiceroleoftgfb1smadsignalingpathway AT ramasamychandramohan geneticdisruptionofguanylylcyclasenatriureticpeptidereceptoratriggersdifferentialcardiacfibrosisanddisordersinmaleandfemalemutantmiceroleoftgfb1smadsignalingpathway AT ramachandransamivel geneticdisruptionofguanylylcyclasenatriureticpeptidereceptoratriggersdifferentialcardiacfibrosisanddisordersinmaleandfemalemutantmiceroleoftgfb1smadsignalingpathway AT oakesjoshuam geneticdisruptionofguanylylcyclasenatriureticpeptidereceptoratriggersdifferentialcardiacfibrosisanddisordersinmaleandfemalemutantmiceroleoftgfb1smadsignalingpathway AT gardnerjasond geneticdisruptionofguanylylcyclasenatriureticpeptidereceptoratriggersdifferentialcardiacfibrosisanddisordersinmaleandfemalemutantmiceroleoftgfb1smadsignalingpathway AT pandeykailashn geneticdisruptionofguanylylcyclasenatriureticpeptidereceptoratriggersdifferentialcardiacfibrosisanddisordersinmaleandfemalemutantmiceroleoftgfb1smadsignalingpathway |